期刊文献+

肝病患者血清血小板生成素水平与血小板计数关系的初步探讨 被引量:1

Study on the Relationship Between the Serum Thrombopoietin(TPO) Levels and Blood Platalet Counts in Patients with Various Kinds of Liver Diseases
下载PDF
导出
摘要 目的:探讨肝病患者血清中血小板生成素(TPO)水平与血小板(PLT)减少的关系。方法:用ELISA方法测定正常人群的及肝病患者的TPO水平。结果:TPO水平在急性肝炎、慢性肝炎轻、中、重度、肝硬化患者与正常人群比较差异无统计学意义(P>0.05);而血小板计数除了急性肝炎组外均差异有统计学意义(P<0.05)。肝病患者血小板正常组(37例)与减少组(40例)TPO水平比较,差异有统计学意义[(136.38±93.49)与(98.65±65.20)μg/L,(P<0.05)];但TPO水平与血小板计数不相关(r=0.1572,P>0.05)。结论:肝病患者血清TPO水平降低可能是致血小板减少的诸多原因之一。 Objective To study the relationship between serum thrombopoietin (TPO) levels and thrombocytopenia in patients with various kinds of liver diseases. Methods Serum TPO levels were determined with ELISA in 102 patients with various kinds of liver diseases ( acute hepatitis n =9, chronic hepatitis n = 80, hepatic cirrhosis n = 13, etiology, HBV infection n = 73, HBV ± HEV n = 13, HEV n = 8, HCV n = 6 autoimmune hepatitis n = 2) and 30 controls. Results The serum TPO levels in patients with various kinds of liver diseases were not significantly different from those in the controls (P 〉 0.05). However, the blood platalet counts were significantly lower in all the patients (with the exception of the nine patients with acute hepatitis) than those in the controls ( P 〈 0. 05 ). If we split the patients with liver diseases into two groups : those with normal platalet count (n = 37) and those with thrombocyto- penia ( n =40), then their TPO levels ( 136.38±93. 491μg/L and 98.65 ± 65.20μg/L) were significantly different from each other ( P 〈 0.05 ). Yet, as a whole, the serum TPO levels were not correlated with the blood platalet count ( r = 0. 1572, P 〉 0.05 ). Oonclusion The lower TPO levels in patients with liver diseases could be only one of the many factors leading to thrombocytopenia.
出处 《放射免疫学杂志》 CAS 2005年第6期512-513,共2页 Journal of Radioimmanology
关键词 肝炎 血小板生成素 血小板减少 肝病 血清 liver diseases, thrombopoietin, thrombocytopenia
  • 相关文献

参考文献11

  • 1Kanshansky K.Thrombopoietin:the primary regulator of megakaryocyte and platelet production.Thromb Haemost.1995,74:521.
  • 2Qian S,Fu F,Li W.primary role of the liver in thrombopoietin production shown by tissue-specific knockout.Blood.1998,92:2189.
  • 3中华医学会传染病与,寄生虫病学分会,肝病学分会.病毒性肝炎防治方案[J].中华肝脏病杂志,2000,8(6):324-329. 被引量:14010
  • 4Sanjo A,Satoi J,Ohnishi A,et al.Role of elevated platelet-associated immunoglobulin G and hypersplenism in thrombocy to penia of chronic liver diseases.J Gastroenterol Hepatol.2003,18:638
  • 5Koike Y,Yoneyama A,Shirai J,et al.Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations.Thromb Haemost.1998,79:1106.
  • 6De sauvage FJ,Hass PE,Spencer SD,et al.stimulation of megakaryocytopoiesis and thrombopoiesis by the C-MPI ligand.Nature.1994,369:533.
  • 7Faeh M,Hauser SP,Nydegger UE.Transiant thrombopoietin peak after liver transplantantion for end-stage liver disease.Br J Haematol.2001,112:493.
  • 8Tsukahara A,Sato Y,Yamamoto S,et al.Thrombopoietin levels and peripheral platelet counts follewing living related donor liver transplantation.Hepatogastroenterology.2003,50:227.
  • 9Nagata Y,Shozaki Y,Nagahisa H,et al.Serum thrombopoietin lever is not regulated by transcription but by the total counts of both megakaryocytes and platelet during thrombocytosis.Thromb Haemost.1997,77:808
  • 10Usuki K,Tahara T,Iki S,et al.Serum thrombopoietin level in various hematological diseases.Stem Cell.1996,14:558.

二级参考文献13

  • 1De Sauvage FJ, Luoh SM, Carver-Moore K, et al. Deficiencies in early and late stages megakaryocytopoiesis in TPO-KO mice. J Exp Med, 1996, 183: 651-656.
  • 2De Sauvage FJ, Hass PE, Spencer SD, et al. Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand.Nature, 1994, 369: 533-538.
  • 3Koike Y, Yoneyama A, Shirai J, et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost, 1998, 79:1106-1110.
  • 4Sanjo A, Satoi J, Ohnishi A, et al. Role of elevated platelet-associated immunoglobnlin G and hypersplenism in thrombocytopenia of chronic liver diseases. J Gastroenterol Hepatol, 2003, 18: 638-644.
  • 5Kuter DJ, Begley CG. Recombinant human thrombopoietin: basic biology and evaluation of clinical studies. Blood, 2002, 100: 3457-3469.
  • 6Goulis J, Chau TN, Jordan S, et al. Thrombopoietin concentrations are low in patients with cirrhosis and thrombocytopenia are restored after orthotopic liver transplantation. Gut, 1999, 44: 754-758.
  • 7Stockelberg D, Andersson P, Bjornsson E, et al. Plasma thrombopoietin levels in liver cirrhosis and kidney failure. J Intern Med,1999, 246: 471-475.
  • 8Shimodaira S, Ishida F, Ichikawa N, et al. Serum thrombopoietin (cMpl ligand) levels in patients with liver cirrhosis. Thromb Haemost,1996, 76: 545-548.
  • 9Peck-Radosavljevic M, Wichlas M, Zadel J, et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood, 2000,95: 795-801.
  • 10Tsukahara A, Sato Y, Yamamoto S, et al. Thrombopoietin levels and peripheral platelet counts following living related donor liver transplantation. Hepatogastroenterology, 2003, 50: 227-230.

共引文献14049

同被引文献8

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部